e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Medicenna Therapeutics Corp
(NQ:
MDNA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Nov 1, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
0.1510 (5)
Ask (Size)
0.1565 (181)
Prev. Close
0.1570
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Dear LUNR Stock Fans, Mark Your Calendars for Jan. 12
October 30, 2023
Intuitive Machines stock is rising on Monday after the company announced plans for a lunar mission launch in January 2024.
Via
InvestorPlace
Why Is Medicenna Therapeutics (MDNA) Stock Down Today?
October 30, 2023
Medicenna Therapeutics stock is falling on Monday after the company announced that shares of MDNA will be delisted from the Nasdaq.
Via
InvestorPlace
Performance
More News
Read More
Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket
October 30, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
October 30, 2023
Via
InvestorPlace
The Latest Analyst Ratings for Medicenna Therapeutics
August 14, 2023
Via
Benzinga
Medicenna Therapeutics's Earnings: A Preview
August 08, 2023
Via
Benzinga
Earnings Preview For Medicenna Therapeutics
February 06, 2023
Via
Benzinga
Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday's Mid-Day Session
October 27, 2023
Via
Benzinga
Nasdaq Jumps 100 Points; Amazon Posts Upbeat Earnings
October 27, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Medicenna Therapeutics Earnings Preview
February 06, 2023
Via
Benzinga
Medicenna's Lead Cancer Program Shows Preliminary Anti-Cancer Activity In Solid Tumor Study
July 27, 2022
Via
Benzinga
Why Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
May 22, 2023
Via
Benzinga
Could CRISPR Therapeutics Help You Become a Millionaire?
December 27, 2022
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022
November 29, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
November 14, 2022
Via
Benzinga
Earnings Scheduled For November 4, 2022
November 04, 2022
Via
Benzinga
Earnings Outlook For Medicenna Therapeutics
November 03, 2022
Via
Benzinga
Medicenna Therapeutics: Q1 Earnings Insights
August 15, 2022
Via
Benzinga
Recap: Medicenna Therapeutics Q1 Earnings
August 15, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
July 14, 2022
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Friday
October 28, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
October 25, 2022
Via
Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
Via
Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
August 10, 2022
Via
Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
August 09, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
wpDiscuz
Insert
